Patents by Inventor Harris Soifer

Harris Soifer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Publication number: 20240024301
    Abstract: Provided herein are methods of tipifarnib in combination with a PI3K inhibitor, such as alpelisib, for treating, preventing or managing head and neck squamous cell carcinoma (HNSCC).
    Type: Application
    Filed: July 20, 2023
    Publication date: January 25, 2024
    Inventors: Francis Burrows, Mollie Leoni, Shivani Malik, Vishnu S. Mishra, Alison Smith, Harris Soifer
  • METHODS OF TREATING URINARY SYSTEM CANCERS
    Publication number: 20220233537
    Abstract: Provided herein are methods of treating an upper tract urothelial carcinoma in a patient by administering to the patient infigratinib or a pharmaceutically acceptable salt thereof. Also provided herein are methods of treating non-muscle invasive bladder cancer by administering to the patient infigratinib or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 29, 2020
    Publication date: July 28, 2022
    Inventors: Riccardo Panicucci, Susan Arangio, Craig Berman, Michael Monteith, Harris Soifer, Gang Li, Carl Dambkowski, Daniel Mulreany
  • Hybrid vectors for gene therapy
    Patent number: 6806080
    Abstract: The invention discloses hybrid vectors for delivering genes or other nucleic acids into mammalian cells. The hybrid vectors of the invention contain both a helper dependent adenoviral portion and a second portion derived from a transposon. Such vectors provide efficient transduction of quiescent cells and provide for stable integration of the gene to be delivered.
    Type: Grant
    Filed: March 19, 2002
    Date of Patent: October 19, 2004
    Assignees: University of Southern California, The Regent of the University of California
    Inventors: Noriyuki Kasahara, Collin Higo, Harris Soifer, Kohnosuke Mitani
  • Hybrid vectors for gene therapy
    Patent number: 6576463
    Abstract: The invention discloses hybrid vectors for delivering genes or other nucleic acids into mammalian cells. The hybrid vectors of the invention contain both a helper dependent adenoviral portion and a second portion derived from either a replication incompetent retrovirus or from a transposon. Such vectors provide efficient transduction of quiescent cells and provide for stable integration of the gene to be delivered.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: June 10, 2003
    Assignee: The Regents of the University of California
    Inventors: Noriyuki Kasahara, Collin Higo, Harris Soifer, Kohnosuke Mitani
  • Hybrid vectors for gene therapy
    Publication number: 20030017597
    Abstract: The invention discloses hybrid vectors for delivering genes or other nucleic acids into mammalian cells. The hybrid vectors of the invention contain both a helper dependent adenoviral portion and a second portion derived from a transposon. Such vectors provide efficient transduction of quiescent cells and provide for stable integration of the gene to be delivered.
    Type: Application
    Filed: March 19, 2002
    Publication date: January 23, 2003
    Inventors: Noriyuki Kasahara, Collin Higo, Harris Soifer, Kohnosuke Mitani